When is Fine Needle Aspiration (FNA) recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Recommend Fine Needle Aspiration (FNA)

Fine Needle Aspiration (FNA) should be used as the first-line modality for histologic assessment for any adult with a neck mass, particularly those at increased risk for malignancy. 1

Indications for FNA

Neck Masses

  • Primary indication: Any adult with a neck mass deemed at increased risk for malignancy 1
  • Risk factors for malignancy in neck masses:
    • Mass present for ≥2 weeks without significant fluctuation or of uncertain duration
    • Physical examination characteristics: fixation to adjacent tissues, firm consistency, size >1.5 cm, or ulceration of overlying skin
    • Other suspicious findings on history and physical examination

Thyroid Nodules

  • Solid nodules >1cm with suspicious ultrasound features 2
  • Any size nodule with highly suspicious features in high-risk patients 2
  • Tender nodules with concerning ultrasound features 2
  • Suspicious ultrasound features include: 2
    • Microcalcifications (highest risk, odds ratio 159)
    • Blurred/ill-defined margins (odds ratio 37)
    • Solid composition (odds ratio 9.9)
    • Hypoechogenicity (odds ratio 2.2)

FNA for Cystic Neck Masses

  • FNA should be used for any adult with a cystic neck mass 1
  • Clinicians should continue evaluation of patients with a cystic neck mass until a diagnosis is obtained and should not assume the mass is benign 1
  • For cystic masses, FNA may need to be repeated, possibly with image guidance to direct the needle into solid components or the cyst wall 1
  • While sensitivity of FNA is lower in cystic cervical metastases (73%) versus solid masses (90%), it remains the recommended first-line diagnostic approach 1

FNA Technique Considerations

  • Ultrasound guidance should be considered when:
    • Initial palpation-guided FNA yields limited diagnostic utility
    • Evaluating cystic or necrotic masses (to target solid components)
    • Dealing with non-palpable nodules 1, 2
  • On-site evaluation by a cytopathologist, when available, can reduce the inadequacy rate of FNA 1
  • For suspected lymphoma, collection of material in tissue culture media is important to allow for immunophenotypic analysis 1
  • When infection is considered, submission of some material for culture is recommended 1

Follow-up After FNA Results

Inadequate or Indeterminate Results

  • Repeat FNA should be attempted prior to resorting to open biopsy for patients with worrisome signs and symptoms 1
  • Add ultrasound guidance for repeat FNA to increase specimen adequacy 1
  • Core biopsy is an option after an initial inadequate or indeterminate FNA, with high adequacy rate (95%) and accuracy (94-96%) 1

Special Considerations

  • If history and physical examination strongly suggest lymphoma, core needle biopsy may be considered as first-line tissue sampling (sensitivity 92% vs 74% for FNA) 1
  • For suspected malignancy where repeated FNA or image-guided FNA are inadequate or benign, expedient open excisional biopsy is recommended 1
  • Excisional biopsy is preferred for cystic masses to reduce the risk of tumor spillage 1

When FNA May Not Be Necessary

  • Solitary nodules in patients with strong family history of thyroid cancer, multiple endocrine neoplasia type II, or history of radiation to head and neck (these patients have >40% risk of thyroid cancer and should undergo surgery) 3
  • Patients with multinodular goiter and compressive symptoms 3
  • Patients with Graves' disease and a thyroid nodule 3
  • Large (>4 cm) or symptomatic unilateral thyroid nodules 3
  • Solitary hyperfunctioning nodules on radioiodine scan with suppressed TSH (extremely low malignancy risk) 3

FNA has dramatically improved the management of neck masses and thyroid nodules, increasing the rate of malignancy in surgically resected thyroid nodules from approximately 14% before routine FNA use to >50% currently 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thyroid Nodule Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Thyroid nodule fine-needle aspiration.

Seminars in ultrasound, CT, and MR, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.